Gilead, Glaxo, Roche gain on swine flu fears
April 27, 2009 at 09:53 AM EDT
Anti-viral developers Gilead Sciences, Roche and GlaxoSmithKline PLC up significantly in early trading on Monday on fears that the swine flu outbreak that started in Mexico could become a global pandemic.
